An expert-led exploration of cancer, delivered by Sona’s CMO, Dr. Carman Giacomantonio. Drawing on his clinical and research experience, Dr. Carman guides viewers through the fundamentals of immunotherapy, the science behind Sona’s innovative Targeted Hyperthermia Therapy (THT), and the future of cancer care. Each installment combines authoritative insight with the latest research, offering a unique perspective for patients, professionals, and the wider medical community.
Latest episode: Providing more Targets for the Immune System
Dr. Carman Giacomantonio explains how immune checkpoint blockades work in cancer therapy, why they often fail, and how Sona’s targeted hyperthermic therapy aims to boost immune recognition and killing of cancer cells.
Episode 1: How does cancer happen?
Dr. Carman breaks down how cancer starts and explores the science behind Sona’s innovative Targeted Hyperthermia Therapy.
Episode 2: Cancer and our Immune System
Dr. Carman breaks down how Learn how cancer uses immune “checkpoints” to escape detection in this week’s Carman’s Corner.
Episode 3: How our immune system responds to cancer?
Dr. Carman explains how the immune system recognizes and responds to cancer. The immune system has two main “arms”: the innate arm and the adaptive arm.
Episode 4: how science is unlocking new possibilities in cancer treatment?
Dr. Carman delves into the fundamentals of immunotherapy, how modern medicine empowers the immune system to fight cancer by overcoming the body’s own checks and balances.
Episode 5: How Modern Immunotherapy Targets Cancer
Dr. Carman Giacomantonio breaks down how the immune system recognizes and attacks cancer, and why immune checkpoints can both protect us and hinder treatment.
Episode 5: Providing more Targets for the Immune System
Dr. Carman Giacomantonio explains how immune checkpoint blockades work in cancer therapy, why they often fail, and how Sona’s targeted hyperthermic therapy aims to boost immune recognition and killing of cancer cells.